Jason S Buhrman MD PhD

PubMed

• 14 citations
  Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid
  Yu Zhang, Jason S. Buhrman, Yang Liu, Jamie E. Rayahin, Richard A. Gemeinhart
  Molecular Pharmaceutics. 2016-05-23
• 37 citations
  Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.
  Dinesh Jaishankar, Jason S. Buhrman, Tibor Valyi-Nagy, Richard A. Gemeinhart, Deepak Shukla
  Investigative Ophthalmology & Visual Science. 2016-01-01
• 364 citations
  High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation
  Jamie E. Rayahin, Jason S. Buhrman, Yu Zhang, Timothy J. Koh, Richard A. Gemeinhart
  ACS Biomaterials Science & Engineering. 2015-06-24

Journal Articles

• Extended release of an anti-heparan sulfate peptide from a contact lens suppresses corneal Herpes Simplex Virus-1 (HSV-1) infection  
  Buhrman JS, Jaishanker, D, Gemeinhart RA, Valyi-Nagy T, Shukla, D, Investigative Ophthalmology and Visual Sciences, 1/1/2016
• Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid  
  Zhang Y, Buhrman JS, Liu Y, Rayahin JE, Gemeinhart RA, Molecular Pharmaceutics, 1/1/2016
• High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation  
  Rayahin JE, Buhrman JS, Gemeinhart RA, ACS Biomaterials Science & Engineering, 1/1/2015
• Melittin, as a glutathione S-transferase fusion protein, maintains anti-inflammatory properties while diminishing toxicity  
  Rayahin JE, Buhrman JS, Gemeinhart RA, European Journal of Pharmaceutical Sciences, 1/1/2014
• Arginine-rich, Cell Penetrating Peptide-microRNA Inhibitor Complexes Decrease Glioblastoma Migration Potential  
  Zhang Y, Köllmer M, Buhrman JS, Tang MY, Gemeinhart RA, Peptides, 1/1/2014
• Active, soluble recombinant melittin purified by extracting insoluble lysate of Escherichia Coli without denaturation  
  Buhrman JS, Rayahin JE, Cook LC, Federle MJ, Gemeinhart RA, Biotechnology Progress, 1/1/2013
• Proteolytic activated anti-bacterial hydrogels  
  Buhrman JS, Cook LC, Rayahin JE, Federle MJ, Gemeinhart RA, Journal of Controlled Release, 1/1/2013
• Markers Are Shared Between Adipogenic and Osteogenic Differentiated Mesenchymal Stem Cells  
  Köllmer M, Buhrman JS, Zhang Y, Gemeinhart RA, Journal of Developmental Biology and Tissue Engineering, 1/1/2013
• Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL12 Enhances Anti-tumor Efficacy in Human Glioblastoma Models  
  Zhang W, Fulci G, Wakimoto H, Cheema T, Buhrman JS, Jeyaretna DS, Stemmer Rachamimov AO, Rabkin SD, Martuza RL, Neoplasia, 1/1/2013
• In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins  
  Buhrman JS, Rayahin JE, Köllmer M, Gemeinhart RA, BMC Biotechnology, 1/1/2012
• Hybrid nanocrystals: University of Kentucky US20060280680A1  
  Rayahin JE, Buhrman JS, Gemeinhart RA, Expert Opinion on Therapeutic Patents, 1/1/2012
• Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma  
  Zhang W, Fulci G, Buhrman JS, Stemmer-Rachamimov AO, Chen JW, Wojtkiewicz GR, Weissleder R, Rabkin SD, Martuza RL, Molecular Therapy, 1/1/2012
• Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging  
  Kleijn A, Chen JW, Buhrman JS, Wojtkiewicz GR, Iwamoto Y, Lamfers ML, Stemmer-Rachamimov AO, Rabkin SD, Weissleder R, Martuza RL, Fulci G, Clinical Cancer Research, 1/1/2011
• Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer  
  Castelo-Branco P, Passer BJ, Buhrman JS, Antoszczyk S, Marinelli M, Zaupa C, Rabkin,SD, Martuza RL, Gene Therapy, 1/1/2010
• Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells  
  Passer BJ, Castelo-Branco P, Buhrman JS, Varghese S, Rabkin SD, Martuza RL, Cancer Gene Therapy, 1/1/2009
• Join now to see all

Books/Book Chapters

• Emerging Cancer Therapy: Emerging Approaches and Biotechnological Tools 
  Chapter: Engineering herpes simplex virus for cancer oncolytic virotherapy 
  Buhrman JS, Cheema TA, Fulci G2010

Abstracts/Posters

• Non-covalent Protein Anchor: Highlight Reel
  Buhrman JS, Medical Scientist Training Program Dinner Seminar, Chicago, IL, 1/3/2015
• Recombinant Protein Immobilization and Controlled-Release Mediated by Versatile, Non-Covalent Protein Anchor
  Buhrman JS, Rayahin JE, Zhang Y, Tang MY, Gemeinhart RA, College of Pharmacy 6th annual research day, University of Illinois at Chicago, Chicago, IL, 1/1/2015
• Controlling MicroRNA Micelleplex Formation and Disassembly
  Zhang Y, Liu Y, Buhrman JS, Gemeinhart RA, College of Pharmacy 6th annual research day, University of Illinois at Chicago, Chicago, IL, 1/1/2015
• Hyaluronan as a regulator of macrophage function: implications for inflammation and angiogenesis
  Rayahin JE, Zhang Y, Buhrman JS, Tang MY, Gemienhart RA, College of Pharmacy 6th annual research day, University of Illinois at Chicago, Chicago, IL, 1/1/2015
• Loading Proteins Throughout the Network of Glutathione-Laden Hydrogels
  Akinrotimi D, Buhrman JS, Gemeinhart RA, Multidisciplinary Oral Sciences Training (MOST) Program Research Forum, Chicago, IL, 1/20/2014
• Recombinant Melittin Protein Loaded Microspheres for Treatment of High Grade Astrocytoma
  Buhrman JS, Rayahin JE, Gemienhart RA, American Institute of Chemical Engineers (AIChE), Chicago, IL, 1/11/2014
• Polymeric modulation of immune cell function
  Rayahin JE, Buhrman JS, Gemeinhart RA, American Institute of Chemical Engineers (AIChE), Chicago, IL, 1/11/2014
• Astrocytoma: Past, present, and future
  Buhrman JS, Waxman J, Medical Scientist Training Program Grand Rounds, University of Illinois, Chicago, IL, 1/2/2014
• Recombinant melittin protein therapy for the treatment of high grade astrocytoma
  Buhrman JS, Rayahin JE, Gemeinhart RA, Multiple Location, 2014, 1/1/2014
• Melittin fusion protein and hyaluronic acid have augmented anti-inflammatory properties when combined
  Rayahin JE, Buhrman JS, Gemeinhart RA, College of Pharmacy 5th Annual Research Day; 41st Annual Meeting of the Controlled Release Society, University of Illinois at Chicago, Chicago, IL, 2014; Chicago, IL, 2014, 1/1/2014
• Exploring Redox Responsive Polymeric Drug Delivery System For Codelivery of Hydrophobic Drug and Silencing RNAs
  Zhang Y, Liu Y, Buhrman JS, Gemeinhart RA, 41st Annual Meeting of the Controlled Release Society, Chicago, IL, 1/1/2014
• Biologically Responsive Recombinant Protein Anchors for Macromolecular Drug Delivery
  Buhrman JS, Rayahin JE, Zhang Y, Tang MY, Gemeinhart RA, The 28th Annual Meeting of the Protein Society; The 12th Annual Chicago Biomedical Consortium Symposium, San Diego, CA, 2014; Chicago, IL, 2014, 1/1/2014
• Hyaluronan as a regulator of macrophage function: implications for inflammation and angiogenesis
  Rayahin JE, Zhang Y, Buhrman JS, Tang MY, Gemienhart RA, Society for Glycobiology Annual Meeting, Honolulu, HI, 1/1/2014
• Biologically Responsive Recombinant Protein Anchors for Macromolecular Drug Delivery
  Buhrman JS, Rayahin JE, Zhang Y, Tang MY, Gemeinhart RA, College of Medicine Research Day, University of Illinois at Chicago, Chicago, IL, 1/1/2014
• Delivering Recombinant Melittin for Treatment of High Grade Astrocytoma
  Buhrman JS, Rayahin JE, Gemeinhart RA, 41st Annual Meeting of the Controlled Release Society, Chicago, IL, 1/1/2014
• Markers Are Shared between Adipogenic and Osteogenic Differentiated Mesenchymal Stem Cells
  Köllmer M, Buhrman JS, Zhang Y, Gemeinhart RA, College of Pharmacy 4th Annual Research Day, University of Illinois at Chicago, Chicago, IL, 1/1/2013
• Degradable Hyaluronic Acid/Interleukin-1 Receptor Antagonist Wafers for Osteoarthritis
  Rayahin JE, Buhrman JS, Gemeinhart RA, College of Pharmacy 4th Annual Research Day, University of Illinois at Chicago, Chicago, IL, 1/1/2013
• Using the glutathione S-transferase:glutathione interaction as a protein anchor in a controlled-release delivery system for cancer treatment
  Buhrman JS, Rayahin JE, Köllmer M, Gemeinhart RA, College of Pharmacy 4th Annual Research Day, University of Illinois at Chicago, Chicago, IL, 1/1/2013
• Imaging Oncolytic Virotherapy Delivery Using a CEST Reporter Gene
  Farrar CT, Buhrman JS, Liu G, Gilad AA, McMahon MT, Fulci G, International Society for Magnetic Resonance in Imaging, Salt Lake City, UT, 1/1/2013
• Non invasive imaging of oncolytic viruses through an MRI sensitive transgene
  Farrar CT, Buhrman JS, Liu G, Kleijn A, Lamfers M, McMahon MT, Gilad AA, Fulci G, 7th Annual Meeting on Replicating Oncolytic Virus Therapeutics, Quebec, Canada, 1/1/2013
• Using the glutathione s-transferase:glutathione interaction as a protein anchor in a controlled-release delivery system for cancer treatment
  Buhrman JS, Rayahin JE, Köllmer M, Gemeinhart RA, Medical Scientist Training Program Annual Retreat, University of Illinois at Chicago, Chicago, IL, 1/1/2013
• Using the glutathione S-transferase:glutathione interaction as a protein anchor in a controlled-release delivery system for cancer treatment
  Buhrman JS, Rayahin JE, Köllmer M, Gemeinhart RA, College of Medicine Research Day, University of Illinois at Chicago, Chicago, IL, 1/1/2012
• Design of Genetic Sequences Encoding a Matrix Metalloproteinase-2-Degradable Synthetic Recombinant Protein
  Cao GY, Buhrman JS, Tang MY, Gemeinhart RA, Illinois Math and Science Acadamy Colloquium, Aurora, IL, 1/1/2011
• Modulating the IL-1 signaling during Glioma Oncolytic Therapy
  Fulci G, Kleijn A, Buhrman J, Collins S, Lamfers M, Rabkin S, Martuza R, Neuro-Oncology 15th Annual Scientific Meeting, Montreal, Canada, 1/1/2010
• Magnetic Resonance Imaging of Viral Spread and Intratumoral Inflammation during Oncolytic Virotherapy
  Kleijn A, Chen JW, Sun PZ, Buhrman JS, Rabkin SD, Weissleder R, Martuza RL, Lamfers ML, Fulci G, Neuro-Oncology 15th Annual Scientific Meeting, Montreal, Canada, 1/1/2010
• Join now to see all